Viral Antigens Market Analysis, Size, and Share by 2031

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Viral Antigens Market Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Component [Influenza Viral Antigens, Coronavirus Antigens, Zika Virus Antigens, Ebola Virus Antigens, Dengue Virus Antigens, Herpes Simplex Virus (HSV) Viral Antigens, Rotavirus Viral Antigens, Hepatitis A-E Virus Antigens, Measles Virus Antigens, Mumps/Parotitis Virus Antigens, and Others], Technique [ELISA, Immunoassay, Hemagglutination, Radioimmunoassay (RIA), Immunoperoxidase Staining, Immunofluorescence, and Others]; End User [Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, and Research Institutes],  and Geography

  • Report Date : Aug 2025
  • Report Code : TIPRE00017334
  • Category : Life Sciences
  • Status : Data Released
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

The Viral Antigens Market size was estimated to be US$ 156.13 million in 2023 and is expected to reach US$ 366.09 million by 2031; it is estimated to record a CAGR of 11.2% till 2031. Development of plant-made vaccine antigens and biopharmaceuticals are likely to remain key Viral Antigens Market trends.

Viral Antigens Market Analysis

The rising prevalence of viral infections worldwide, including, HIV, influenza, hepatitis, and respiratory viruses like COVID-19, drives the demand for viral antigens which are used in diagnostic studies. Advancements in molecular biology, government initiatives for vaccine development against emerging viruses, increasing R&D activities for diagnostic technique development and vaccine development, and increasing investment in viral antigen research is fueling the growth of the viral antigen market.

Viral Antigens Market Overview

A virus can infect all types of life forms, from plants and animals to archaea and bacteria. A virus antigen is a poison or toxic substance administered by a virus that induces an immune reaction in its host. A viral protein is an antigen identified by the viral genome that can be recognized through a particular immunological response. A viral antigen is determined by IFA in neutrophils and platelets from bone marrow or blood or in serum, saliva, tears, or plasma by ELISA. Nucleic amplification tests can also be used to determine the stage of infection. The best outcomes are obtained when antigens are measured through blood tests or serum.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Viral Antigens Market: Strategic Insights

viral-antigens-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Viral Antigens Market Drivers and Opportunities

Increased Awareness of Viral Antigens in Vaccine Development

Viral antigens play an important role in vaccine development, as they are the component detected by immune system for protection. For instance, when a person is infected with a virus, their immune system recognises specific viral antigens as foreign and mounts a response to eliminate the virus. Viral antigens in vaccines exposes the immune system to these specific anitgens in a controlled manner and thus helping the person to develop immune response against the virus.  The development and use of vaccines has greatly reduced the number of illnesses and diseases over the years. The introduction of a variety of new types of vaccines has been made possible through the manipulation of DNA, RNA, proteins and sugars, increased knowledge of immune response, and a major leap in genetic engineering. Development of attenuated mutants, expression of possible antigens in live vectors, and purification and direct synthesis of antigens in new systems have significantly enhanced the vaccine technology. Thus, increased acceptance of viral antigens in vaccine development is expected to drive the market during the forecast period.

Growing Awareness about Preventive Healthcare – An Opportunity of Viral Antigens Market

Preventive healthcare focuses on preventing health problems from occurring and also focuses on diagnosing problems before any symptoms or complications are developed. Vaccination plays a crucial role in preventive healthcare as it can build a person’s immunity for the viral infections before the person is exposed to the virus. In case of preventive healthcare, the vaccines developed are generally made up of viral antigens so that the immune system detect them. Thus, increasing awareness about preventive healthcare through vaccination is fueling the growth of the viral antigens market.

Viral Antigens Market Report Segmentation Analysis

Key segments that contributed to the derivation of the Viral Antigens Market analysis are component, technique, and end user.

  • Based on component, the Viral Antigens Market is segmented into Influenza Viral Antigens, Coronavirus Antigens, Zika Virus Antigens, Ebola Virus Antigens, Dengue Virus Antigens, Herpes Simplex Virus (HSV) Viral Antigens, Rotavirus Viral Antigens, Hepatitis A-E Virus Antigens, Measles Virus Antigens, Mumps/Parotitis Virus Antigens, and others. The influenza viral antigens segment held the largest market share in 2023. Around 2,000 influenza viruses are antigenically characterized by the CDC each year to compare how similar currently circulating influenza viruses are to those used in the influenza vaccine and to detect changes in circulating influenza viruses. Antigenic characterization may imply the capacity of the flu vaccine to induce an immune response against influenza viruses that circulate in humans.
  • By technique, the market is segmented into ELISA, Immunoassay, Hemagglutination, Radioimmunoassay (RIA), Immunoperoxidase Staining, Immunofluorescence, and Others. The ELISA segment held the largest share of the market in 2023.
  • In terms of end user, the market is segmented into Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, and Research Institutes. The diagnostic segment dominated the market in 2023.

Viral Antigens Market Share Analysis by Geography

The geographic scope of the Viral Antigens Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America has dominated the Viral Antigens Market. In North America, the US holds the significant share of the multiple sclerosis therapeutics market. The growth of the market in the country is primarily driven by vast number of R&D activities for development of vaccination, financial aids by governments, other private, and non-private organizations for vaccination druves, and increasing prevalence of viral infections in the country. Additionally, increasing awareness regarding the preventive healthcare is expected to boost the adoption and acceptance of the products during the forecast period.

Viral Antigens Market Regional Insights

The regional trends and factors influencing the Viral Antigens Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Viral Antigens Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

viral-antigens-market-global-geography
  • Get the Regional Specific Data for Viral Antigens Market

Viral Antigens Market Report Scope

Report Attribute Details
Market size in 2023 US$ 156.13 Million
Market Size by 2031 US$ 366.09 Million
Global CAGR (2023 - 2031) 11.2%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Component
  • Influenza Viral Antigens
  • Coronavirus Antigens
  • Zika Virus Antigens
  • Ebola Virus Antigens
  • Dengue Virus Antigens
  • Herpes Simplex Virus Viral Antigens
  • Rotavirus Viral Antigens
  • Hepatitis A-E Virus Antigens
  • Measles Virus Antigens
  • Mumps/Parotitis Virus Antigens
By Technique
  • ELISA
  • Immunoassay
  • Hemagglutination
  • Radioimmunoassay
  • Immunoperoxidase Staining
  • Immunofluorescence
By End User
  • Hospitals
  • Clinics
  • Laboratories
  • Diagnostic Centers
  • Blood Banks
  • Research Institutes
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Microbix Biosystems
  • BIO-RAD LABORATORIES INC.
  • Creative Diagnostics
  • Aalto Bio Reagents Ltd.
  • Advanced Biotechnologies Inc.
  • Prospec-Tany Technogene Ltd.
  • ACROBiosystems.
  • MERIDIAN BIOSCIENCE, INC.
  • Rekom Biotech S.L
  • LGC Limited

  • Viral Antigens Market Players Density: Understanding Its Impact on Business Dynamics

    The Viral Antigens Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Viral Antigens Market are:

    1. Microbix Biosystems
    2. BIO-RAD LABORATORIES INC.
    3. Creative Diagnostics
    4. Aalto Bio Reagents Ltd.
    5. Advanced Biotechnologies Inc.
    6. Prospec-Tany Technogene Ltd.

    Disclaimer: The companies listed above are not ranked in any particular order.


    viral-antigens-market-cagr

    • Get the Viral Antigens Market top key players overview

    Viral Antigens Market News and Recent Developments

    The Viral Antigens Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for viral antigens and strategies:

    • Sino Biological Inc launched the world largest recombinant viral antigen collection, ProVir. The product line features a wide range of high quality recombinant proteins expressed in insect and mammalian cells. These products are rigorously tested for their purity and bioactivity. This portfolio includes over 800 products from 45 different types, 350 strains of viruses. (Source: Sino Biological Inc, Company Website, 2020)

    Viral Antigens Market Report Coverage and Deliverables

    The “Viral Antigens Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles
    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo